Corrigendum: Unravelling the therapeutic potential of botanicals against chronic obstructive pulmonary disease (COPD): molecular insights and future perspectives(Front. Pharmacol., (2022), 13, (824132), 10.3389/fphar.2022.824132)

Sicon Mitra; Uttpal Anand; Mimosa Ghorai; Balachandar Vellingiri; Niraj Kumar Jha; Tapan Behl; Manoj Kumar; Radha; Mahipal S. Shekhawat; Jarosław Proćków; Abhijit Dey

doi:10.3389/fphar.2024.1365790

Corrigendum: Unravelling the therapeutic potential of botanicals against chronic obstructive pulmonary disease (COPD): molecular insights and future perspectives(Front. Pharmacol., (2022), 13, (824132), 10.3389/fphar.2022.824132)

Sicon Mitra, Uttpal Anand, Mimosa Ghorai, Balachandar Vellingiri, Niraj Kumar Jha, Tapan Behl, Manoj Kumar, Radha, Mahipal S. Shekhawat, Jarosław Proćków, Abhijit Dey

Research output: Contribution to journal › Comment/debate

Abstract

In the published article, there was an error in the Affiliation information about Uttpal Anand [2]. Instead of “Department of Life Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel,” it should be “CytoGene Research & Development LLP, Lucknow, Uttar Pradesh, India.” As a result of the change in affiliation above, the Conflict of Interest statement must be amended to the following.

Original language	English
Article number	1365790
Journal	Frontiers in Pharmacology
Volume	15
DOIs	https://doi.org/10.3389/fphar.2024.1365790
State	Published - 1 Jan 2024
Externally published	Yes

Keywords

COPD
COVID-19
alternative therapy
clinical efficacy
inflammation
lungs
medicinal plants
plant-based formulation

ASJC Scopus subject areas

Pharmacology
Pharmacology (medical)

Access to Document

10.3389/fphar.2024.1365790

Fingerprint

Dive into the research topics of 'Corrigendum: Unravelling the therapeutic potential of botanicals against chronic obstructive pulmonary disease (COPD): molecular insights and future perspectives(Front. Pharmacol., (2022), 13, (824132), 10.3389/fphar.2022.824132)'. Together they form a unique fingerprint.

Cite this

Mitra, S., Anand, U., Ghorai, M., Vellingiri, B., Jha, N. K., Behl, T., Kumar, M., Radha, Shekhawat, M. S., Proćków, J., & Dey, A. (2024). Corrigendum: Unravelling the therapeutic potential of botanicals against chronic obstructive pulmonary disease (COPD): molecular insights and future perspectives(Front. Pharmacol., (2022), 13, (824132), 10.3389/fphar.2022.824132). Frontiers in Pharmacology, 15, Article 1365790. https://doi.org/10.3389/fphar.2024.1365790

@article{40e8d851327f49ed83eea12612496106,

title = "Corrigendum: Unravelling the therapeutic potential of botanicals against chronic obstructive pulmonary disease (COPD): molecular insights and future perspectives(Front. Pharmacol., (2022), 13, (824132), 10.3389/fphar.2022.824132)",

abstract = "In the published article, there was an error in the Affiliation information about Uttpal Anand [2]. Instead of “Department of Life Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel,” it should be “CytoGene Research & Development LLP, Lucknow, Uttar Pradesh, India.” As a result of the change in affiliation above, the Conflict of Interest statement must be amended to the following.",

keywords = "COPD, COVID-19, alternative therapy, clinical efficacy, inflammation, lungs, medicinal plants, plant-based formulation",

author = "Sicon Mitra and Uttpal Anand and Mimosa Ghorai and Balachandar Vellingiri and Jha, {Niraj Kumar} and Tapan Behl and Manoj Kumar and Radha and Shekhawat, {Mahipal S.} and Jaros{\l}aw Pro{\'c}k{\'o}w and Abhijit Dey",

note = "Publisher Copyright: Copyright {\textcopyright} 2024 Mitra, Anand, Ghorai, Vellingiri, Jha, Behl, Kumar, Radha, Shekhawat, Pro{\'c}k{\'o}w and Dey.",

year = "2024",

month = jan,

day = "1",

doi = "10.3389/fphar.2024.1365790",

language = "English",

volume = "15",

journal = "Frontiers in Pharmacology",

issn = "1663-9812",

publisher = "Frontiers Media SA",

}

Mitra, S, Anand, U, Ghorai, M, Vellingiri, B, Jha, NK, Behl, T, Kumar, M, Radha, Shekhawat, MS, Proćków, J & Dey, A 2024, 'Corrigendum: Unravelling the therapeutic potential of botanicals against chronic obstructive pulmonary disease (COPD): molecular insights and future perspectives(Front. Pharmacol., (2022), 13, (824132), 10.3389/fphar.2022.824132)', Frontiers in Pharmacology, vol. 15, 1365790. https://doi.org/10.3389/fphar.2024.1365790

Corrigendum: Unravelling the therapeutic potential of botanicals against chronic obstructive pulmonary disease (COPD): molecular insights and future perspectives(Front. Pharmacol., (2022), 13, (824132), 10.3389/fphar.2022.824132). / Mitra, Sicon; Anand, Uttpal; Ghorai, Mimosa et al.
In: Frontiers in Pharmacology, Vol. 15, 1365790, 01.01.2024.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Corrigendum

T2 - Unravelling the therapeutic potential of botanicals against chronic obstructive pulmonary disease (COPD): molecular insights and future perspectives(Front. Pharmacol., (2022), 13, (824132), 10.3389/fphar.2022.824132)

AU - Mitra, Sicon

AU - Anand, Uttpal

AU - Ghorai, Mimosa

AU - Vellingiri, Balachandar

AU - Jha, Niraj Kumar

AU - Behl, Tapan

AU - Kumar, Manoj

AU - Radha,

AU - Shekhawat, Mahipal S.

AU - Proćków, Jarosław

AU - Dey, Abhijit

PY - 2024/1/1

Y1 - 2024/1/1

N2 - In the published article, there was an error in the Affiliation information about Uttpal Anand [2]. Instead of “Department of Life Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel,” it should be “CytoGene Research & Development LLP, Lucknow, Uttar Pradesh, India.” As a result of the change in affiliation above, the Conflict of Interest statement must be amended to the following.

AB - In the published article, there was an error in the Affiliation information about Uttpal Anand [2]. Instead of “Department of Life Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel,” it should be “CytoGene Research & Development LLP, Lucknow, Uttar Pradesh, India.” As a result of the change in affiliation above, the Conflict of Interest statement must be amended to the following.

KW - COPD

KW - COVID-19

KW - alternative therapy

KW - clinical efficacy

KW - inflammation

KW - lungs

KW - medicinal plants

KW - plant-based formulation

UR - http://www.scopus.com/inward/record.url?scp=85188269349&partnerID=8YFLogxK

U2 - 10.3389/fphar.2024.1365790

DO - 10.3389/fphar.2024.1365790

M3 - Comment/debate

C2 - 38515842

AN - SCOPUS:85188269349

SN - 1663-9812

VL - 15

JO - Frontiers in Pharmacology

JF - Frontiers in Pharmacology

M1 - 1365790

ER -

Mitra S, Anand U, Ghorai M, Vellingiri B, Jha NK, Behl T et al. Corrigendum: Unravelling the therapeutic potential of botanicals against chronic obstructive pulmonary disease (COPD): molecular insights and future perspectives(Front. Pharmacol., (2022), 13, (824132), 10.3389/fphar.2022.824132). Frontiers in Pharmacology. 2024 Jan 1;15:1365790. doi: 10.3389/fphar.2024.1365790

Corrigendum: Unravelling the therapeutic potential of botanicals against chronic obstructive pulmonary disease (COPD): molecular insights and future perspectives(Front. Pharmacol., (2022), 13, (824132), 10.3389/fphar.2022.824132)

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this